Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Acute Renal Failure
Interventions
DEVICE

Renal tubule assist device

Standard hemofiltration cartridge containing nonautologous human renal tubule cells, connected to conventional continuous venovenous hemodialysis circuit.

Trial Locations (13)

21201

University of Maryland, Baltimore

23219

Virginia Commonwealth University, Richmond

28208

Southeast Renal Associates/Presbyterian Hospital, Charlotte

30912

Medical College of Georgia, Augusta

35203

University of Alabama, Birmingham

44195

Cleveland Clinic Foundation, Cleveland

46202

Indiana University, Indianapolis

48109

University of Michigan, Ann Arbor

60637

University of Chicago, Chicago

77004

University of Texas, Houston

02114

Massachusetts General Hospital, Boston

01107

Western New England Renal and Transplant Associates, Springfield

02903

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

RenaMed Biologics

INDUSTRY